Entheon Biomedical Corp.
Entheon Biomedical Corp.
Indice CSE:
Devise:
Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.
Entheon Biomedical Corp. (ENBI)
SEDAR Information
Information d'entreprise
Addresse
211-3030 Lincoln Avenue
Coquitlam, BC V3B 6B4
CanadaTéléphone
604-562-3932Courriel
[email protected]URL
https://entheonbiomedical.com/Date d’inscription à la cote
Jeudi, mai 3, 2018
Agent de transfert
Computershare Investor Services Inc.Capitalisation
Capitalisation:
8858934Réservé à l'émission:
3295000Company Officers
Timothy Ko, CEO
Soo-Whan Kim, Interim CFO
Kelly Pladson, Corporate Secretary
Communiqués de presse
Bulletins
28/02/2024
2024-0235 – Consolidation - Entheon Biomedical Corp. (ENBI)
Le 28 février/February 2024
Entheon Biomedical Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 5,908,926 common shares.
The name and symbol will not change.
